You are here: All Products  > IASO Starts China Phase I/II Trial of CD19/CD22 CAR-T for Lymphoma

IASO Starts China Phase I/II Trial of CD19/CD22 CAR-T for Lymphoma

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products